Diabetes technology advancements in continuous glucose monitoring (CGM) systems over the last 20+ years have led to integrated CGM (iCGM) devices that allow communication with other technology, including software and continuous subcutaneous insulin-infusion devices (insulin pumps). This expands the ability to prevent hyperglycemia and hypoglycemia beyond an alert -- if clinicians, caregivers, and patients understand how to use the technology. To help healthcare professionals and patients make decisions regarding diabetes technology, this collection page features a series of educational activities that review available CGM devices, how to use and interpret CGM data from the ambulatory glucose profile (AGP) report, and the role of the entire diabetes multidisciplinary healthcare team. In addition, there could be a benefit to continuously and passively measure the levels of ketones in the blood through continuous ketone monitoring technology as hormone imbalances caused by diabetic ketoacidosis results in production of ketones by the liver, lowering blood pH that can, if left unchecked, cause severe organ damage or death.
The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.
The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Medscape Education© Medscape, LLC